22 October 2024

Nation Clinic Pioneers Mobile Healthcare with a Scalable Franchise Model
Nation Clinic, an innovative mobile healthcare platform specializing in diagnostics, prevention, and therapy, is set to transform access to high-quality medical services through a fleet of mobile clinics. Designed to deliver advanced, personalized care directly to patients, Nation Clinic aims to bridge gaps in traditional healthcare by addressing medication adherence challenges, improving access to early diagnostics, and reducing overall healthcare costs.
Equipped with cutting-edge diagnostic tools and a proprietary data analytics platform, Nation Clinic’s mobile units will provide rapid on-site testing, remote GP consultations, and tailored treatment solutions—all within a seamless, patient-centric model.

”As healthcare costs continue to rise and accessibility remains a global challenge, we see an urgent need for a more patient-focused approach,“ said Dr. Alexey Shulepov, Co-Founder of Nation Clinic. ”Our mobile platform not only delivers high-quality diagnostics and treatment directly to people’s doorsteps but also leverages advanced data analytics to enhance preventive care and long-term health outcomes“

The company’s vision extends beyond London, with a scalable franchise model designed for rapid expansion into major metropolitan areas worldwide. Nasib Piriyev, Co-Founder of Nation Clinic, added: ”Scalability is at the core of our strategy. By implementing a franchise-based model, we can quickly enter new markets, providing a cost-efficient and highly effective alternative to traditional healthcare infrastructure. This approach ensures standardized service quality while enabling local healthcare professionals to operate their own mobile units under the Nation Clinic brand. Additionally, we are developing a powerful
AI engine that will continuously build a comprehensive picture of each patient’s health based on their diagnostic tests and treatments, enabling a truly personalized and data-driven approach to long-term care.“
Pilot Launch in Chelsea & Kensington
Nation Clinic is set to launch its first pilot operations in Chelsea and Kensington in Q1 2025, showcasing the full capabilities of its mobile units ahead of broader expansion. The Minimum Viable Product (MVP) is on track for completion by early 2025, enabling live demonstrations and real-world testing.

With a projected five-year revenue of $300 million and an EBITDA of $60 million, Nation Clinic is attracting strong investor interest, particularly from those with expertise in healthcare and franchising. The company is currently preparing for the MVP launch and subsequent fundraising to support its next phase of expansion, with a key focus on entering the US market.

For more information, partnership opportunities, or investment inquiries, please visit nation.clinic or contact office@woodford-finance.com.